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Summary. Sera from 144 healthy blood donors were screened 
for the presence of antibody against the bladder carcinoma cell 
line R T4 by means of an immune adherence assay. Only one 
serum (9241) demonstrated high activity with a titer of 1/124. 
Qualitative and quantitative absorption analyses were carried 
out with a wide variety of cells to characterize the specificity of 
the reaction. Cells used for absorption were both cultured and 
non-cultured and normal and malignant. The reactivity was 
absorbed by the bladder cancer cell lines RT4 and 5637 and the 
lung cancer cell line SK-LC-LL. In addition, surgically 
obtained urothelium from a patient with transitional cell 
carcinoma abrogated reactivity. No other absorbing cells 
removed the reactivity of serum 9241 for RT4. The antigen 
defined by this serologic reaction is heat-stable and trypsin- 
resistant, as demonstrated by using heated or trypsinized RT4 
cells for absorption. 
This study shows that naturally occurring antibody directed 
toward cell surface antigens of tumor cells is present in some 
normal individuals. This finding is important in the evaluation 
of a possible causal relationship between the presence of 
antibody specific for tumor cell antigens and the development of 
neoplasia. 
Introduction 
Autologous serologic typing of human tumor antigens has been 
applied to the study of cell surface antigens of malignant 
melanoma [1, 10, 11], acute leukemia [4], astrocytoma [9], and 
renal carcinoma [14]. Autologous typing is a method that uses 
autologous combinations of serum and target cells to eliminate 
alloantigens as a source of positive reactions. The character- 
ization of these antigens by absorption analysis has resulted in 
the definition of three classes according to the specificity of the 
system being studied. Class 1 antigens are limited to autolo- 
gous tumor cells and cannot be detected by absorption on any 
other normal or malignant cells. Class 2 antigens are found on 
autologous as well as certain allogeneic tumors, but not on 
normal cells. Class 3 antigens are detected on a wide variety of 
normal and malignant cells of both human and animal 
origin. 
Autologous typing has clearly demonstrated serological 
reactivity to surface antigens on cultured tumor cells by 
patients with several different tumors. The existence of 
antibody specific for tumor-cell-restricted antigens raises the 
question as to whether the presence of antibody is causally 
related to neoplasia. In order to understand the relationship of 
antibody to the presence of tumor, a normal population needs 
to be surveyed to determine whether specific naturally 
occurring antibody directed toward cell surface antigens of 
tumor cells is present in normal individuals. In such a study 
performed on melanoma target cells, 6 of 106 normal males 
had antibody to a class 2 melanoma surface antigen [6]. To 
determine whether this occurs with other neoplasms, natural 
antibody was searched for against the bladder carcinoma cell 
line RT4. 
Materials and Methods 
Tissue Culture, All cell cultures except for lymphoid lines were 
maintained with Eagle's MEM supplemented with 1% non-es- 
sential amino acids, 2 mM glutamine, 100 units penicillin/mI, 
100 ~g streptomycin/ml, and 10% fetal bovine serum (FBS). 
Epstein-Barr virus (EBV)-transformed lymphoblast and Raji 
cell lines were maintained in RPMI 1640 with 2 mM glutamine, 
1% non-essential amino acids, penicillin 100 units/ml, strep- 
tomycin 100 ~g/ml, and 10% FBS. In order to remove 
heterologous FBS components, RT4 cells were cultured in 
10% human A positive serum for at least five passages. 
Cells in tissue culture were fed with medium two or three 
times weekly, depending on growth characteristics and the size 
of the tissue culture flask. The cell lines were subcultured at 
intervals ranging from once a week to once a month. Cultures 
were repeatedly checked for contamination with mycoplasma, 
fungi, and bacteria. Contaminated cultures were discarded. 
SK-GR-1 was derived from a thoracic metastasis of a 
patient with embryonal carcinoma. The bladder carcinomas 
RT4, SCaBER, SW-800, 5637, and 253J; the lung carcinomas 
Calu-1 and Calu-3; and the malignant teratoma Tera:l were 
supplied by Dr J. Fogh, Sloan-Kettering Institute. The deri- 
vations of other cell lines have been noted elsewhere [1, 3, 4, 6, 
9-11, 14]. 
Sera. Sera were collected from healthy blood donors and 
stored at -70  ° C. Serum 9241 was obtained from a healthy 
non-transfused 34-year-old Caucasian male. Anti-A and anti-B 
sera were obtained from Hyland, Division of Travenol 
Laboratories, Inc., Costa Mesa, CA, USA. 
Serological Procedures. The immune adherence assay (IA) was 
performed as previously described and modified for Falcon 
3034 plates (Falcon Labware, Division of Becton, Dickinson & 
Co., Oxnard, CA, USA [10, 14]. 
In brief, target cells were trypsinized, washed, and seeded 
into Falcon 3034 plates at a density of 200 cells/well (0.01 ml). 
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Plates were incubated at 37 ° C with humidified 5% CO2 and 
used 2 - 4  days thereafter. Sera were diluted in Veronal buffer 
medium (VBM) with 5% FBS (VBM-FBS). The wells were 
washed three times with VBM-FBS and once with VBM, after 
which 0.01 ml of diluted serum was added per well. The plates 
were incubated at 4 ° C for I h and again washed. Indicator cells 
(0.5% human 0 erythrocytes and guinea pig serum as a source 
of complement diluted 1/80 in VBM) were added in 0.01 ml 
aliquots to each well. The plates Were incubated at 37 ° C with 
humidified 5% CO 2 for 30 min. After incubation, the plates 
were gently washed once with VBM-FBS and evaluated under 
a light microscope. In later experiments (PBS-ALB) phos- 
phate-buffered saline with 0.2% albumin (Miles Laboratories, 
Inc., Elkhart,  IN 46515, USA) was substituted for VBM and 
VBM-FBS. An individual target cell was scored as positive 
when 50% or more of its perimeter was surrounded by 
indicator cells. When test cells grown in medium containing 
human serum were used, assays were done with either 
dextrose-gelatin-veronal buffer (DGV) or PBS-ALB used as 
the diluent and washing agent, with identical results. 
Qualitative absorption tests were performed by absorbing 
30 ~tl serum (25 ~tl for quantitative absorptions) diluted 
according to the end-point with 20 ~tl (8 x 104 to 2 x 107 cells 
for quantitative absorptions) of washed packed cells for 1 h at 
4 ° C and testing for residual antibody on target cells grown in 
Falcon 3034 plates. Heat  stability of antigen was determined by 
heating cells for 5 rain at 100°C and then performing 
qualitative absorption. All absorption tests were performed on 
at least two separate days except for normal kidney cells EQ,  
FJ, FR, FS, and skin fibroblast cells DY, EP, FL, FS. 
Fresh human urothelium was used for absorptions in four 
instances. These specimens were removed for medically 
indicated reasons and a portion was used for this study. The 
specimens were aseptically transferred to the laboratory and 
kept in phosphate-buffered saline with penicillin 100 units/ml 
and streptomycin 100 ~tg/ml at 4 ° C until use (approximately 
24 h later). At  the time of absorption, the urothelial surface 
was gently scraped off with a scalpel and the cells were then 
washed and packed for qualitative absorption. Because of the 
limited numbers of cells available, each of these absorptions 
could be performed only once. 
R e s u l t s  
Reactions of Normal Human Sera with RT4 
Sera from 144 healthy blood donors were screened at dilutions 
of 1/4, 1/16, and 1/64 against RT4 bladder carcinoma cells with 
the I A  assay. One hundred twenty-four had no titer (less than 
50% reactivity at 1/4 dilution), eighteen had a titer of 1/4, and 
one had a titer of 1/16. Only one serum (9241) exhibited 
significant reactivity with a titer of 1/124 on subsequent testing. 
Blood group A and B antigens do not account for these results. 
RT4 was derived from a blood group 0 male and does not 
express blood group A or B antigens as determined by IA 
assays with anti-A and anti-B sera against RT4 target cells. 
Serum 9241 was obtained from a healthy, non-transfused 
34-year-old Caucasian male who is blood type 0 positive. 
Samples of serum collected over a 6-month period exhibited 
similar reactivity. 
Qualitative Absorption Analysis of 9241 
Figure 1 illustrates an individual absorption and Table 1 
summarizes the results of the analysis. The bladder cancer lines 
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Fig. 1. Qualitative absorption analysis of serum 9241 for bladder 
cancer RT4. RT4 completely removed reactivity of serum 9241. Sheep 
erythrocytes (SRBC), DY skin fibroblasts, EQ normal kidney, renal 
cancers Caki-1 and SK-RC-16, and melanomas SK-MEL-37 and 
MeWo did not remove reactivity. ( & - - - & )  Unabsorbed serum; 
( O - - - O )  SRBC; (A ..... A) DY skin fibroblasts; ( © - - - © )  EQ 
normal kidney; ([:3 ..... n) Caki-I; (V ..... V) SK-MEL-37; ( I  ..... I )  
SK-RC-16; ( ® - - - ® )  MeWo; ( V - - - Y )  RT4 
Table 1. Summary of IA absorbtion of serum 9241 for RT4 
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Table 2. Summary of absorptions with human urothelium 
Speci- Age Sex Race Blood Operation Pathologic diagnosis Tissue for Absorption 
men type absorption with 9241 
1 45 F C B pos. Pyeloplasty Fibrosis of lamina Renal pelvis Negative 
propria 
2 51 M C AB pos. Radical nephrectomy Renal carcinoma Ureter Negative 
3 56 M C 0 pos. Nephroureterectomy Grade I transitional Renal pelvis Complete 
cell carcinoma and ureter 
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Fig. 2. Quantitative absorption analysis of serum 9241 for bladder 
carcinoma RT4. Aliquots of 1/3 diluted serum were absorbed with 
counted numbers of RT4, 253J, 5637, and SK-LC-LL cells and then 
tested for residual IA activity for RT4 cells. The bladder cancers RT4 
and 5637 and the lung cancer SK-LC-LL completely removed 
reactivity. There was no absorption by the bladder carcinoma 253J. 
([3) 253J; (0) RT4; (&) 5637; (A) SK-LC-LL 
RT4 and 5637 and the lung cancer line SK-LC-LL were the 
only cell lines which absorbed reactivity. Other bladder 
carcinoma cell lines and other malignant cell lines did not 
abrogate reactivity. Similarly, cultured normal kidney cells, 
fibroblasts, fetal cells, xenogenic cells, and red blood cells did 
not remove activity. To further rule out alloantigens of the 
H L A  complex, lymphoblast cell lines transformed with EBV 
were used for absorption and yielded negative results. 
Antigens related to FBS were eliminated because RT4 cells 
grown in human A positive serum for five passages completely 
absorbed the antibody. Absorption analysis demonstrated the 
heat-stability and trypsin-resistant nature of the antigen. There 
was equal absorption with RT4 whether harvested by scraping 
or trypsinization. In addition, RT4 continued to absorb 
reactivity after heating to 100°C for 5 rain. 
Quantitative Absorption Analysis of 9241 
To further evaluate the qualitative absorptions by RT4, 5637, 
and SK-LC-LL, quantitative absorptions were performed 
as illustrated in Fig. 2. These demonstrate identical absorp- 
tion patterns and suggest that these cell fines present an 
equal amount of the antigen(s) per cell as defined by 
serum 9241. 
Qualitative Absorptions with Human Urothelium 
Four absorptions were performed with normal urothelium 
from surgical specimens. Clinical data and absorption results 
are shown in Table 2. Specimens 1, 2, and 4 were from patients 
who had no history of transitional cell carcinoma. None of 
these specimens abrogated reactivity in a qualitative absorp- 
tion analysis. Specimen 3 was taken from a nephroureterec- 
tomy specimen containing several areas of grade I transitional 
cell carcinoma. Grossly and histologically normal urothelium 
from the ureter and renal pelvis completely absorbed reactivity 
by 9241. 
Discussion 
The first report af a specific naturally occurring antibody to 
tumor cell surface antigens in a healthy human was published 
in 1980 [6]. Houghton and co-workers demonstrated the 
existence of natural antibody to a class 2 (tumor shared) 
antigen on a cultured melanoma cell line with an anti-C3 mixed 
hemadsorption assay. When the IA assay was used on three 
different melanoma targets the proportion of positive reactions 
for sera with a titer of at least 1/8 ranged from 5.6% to 15.1%. 
The prevalence of sera with a similar degree of reactivity to 
RT4 in my study was only 1.3%. 
RT4 was derived from a blood type 0 male (J. Fogh, 
personal communication) and does not express blood group A 
or B antigens in tissue culture. Absorptions with human A and 
B erythrocytes confirmed that the ovserved reactions were not 
blood group-related. The complete absorption of activity by 
RT4 grown in human serum for more than five passages is good 
evidence that FBS alloantigens are not the source of the 
positive reactions. Alloantibodies to HLA products cannot be 
completely eliminated because of the lack of autologous 
normal cells for absorption, but are unlikely because the serum 
was derived from a non-transfused male and because of the 
extensive negative absorptions including EBV-transformed 
lymphoblast cell lines. Serum 9241 defines a class 2 antigen 
that is shared by one other bladder carcinoma and a lung 
carcinoma. The antigen is both heat- and trypsin-stable, 
suggesting that it may not be a protein. It may be chemically 
more similar to the class 2 melanoma antigen AH, which is a 
glycolipid [8], as opposed to the prototype class i melanoma 
antigen AU,  which is a glycoprotein [2]. 
Absorptions with surgically obtained human urothelium 
from three patients with benign urologic diseases did not 
abrogate reactivity. The sole absorption from a patient with 
transitional cell carcinoma removed reactivity even though the 
urothelium was from grossly and histologically normal areas. 
There are several possible explanations for this. The first is that 
the patient with transitional cell carcinoma shares a highly 
restricted HLA antigen with RT4. This is unlikely for the 
reasons discussed above, but remains a consideration when- 
ever one is dealing with allogeneic analysis. The second is that 
unrecognized areas of tumor cells were present in the tissue 
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used for absorption and that the antibody is directed at an 
antigen restricted to tumor cells. The third is that some tumor 
cells manifest this antigen early in the development of the 
carcinogenic phenotype prior to the development of changes 
visible by conventional light microscopy. The separation of 
these latter two possibilities is not possible at this point in the 
analysis, and, in fact, both are possible. Transitional cell 
carcinoma is known to be a field change disease [12] in at least 
some cases, and early changes prior to gross neoplasia have 
been documented [13]. 
The significance of natural antibody is unclear. The 
discovery of this phenomenon is somewhat similar to the 
finding of natural killer (NK) cells in cell-mediated immunity 
[5, 7]. Whether or not these phenomena play any role in 
immunologic surveillance is purely speculative at this point. 
Further screening of different populations and tumor types and 
follow-up of the individuals studied may yield some clues to 
this problem. 
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